SCHEMBL24136226

SCHEMBL24136226

CNc1nc(Cl)nc2[nH]cc(C(F)(F)F)c12

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.38
YTHDC1 Q96MU7 3/20 0.38
HSP90AB1 P08238 1/20 0.36
CHUK O15111 1/20 0.36
LRRK2 Q5S007 4/20 0.34
CYP1A2 P05177 3/20 0.34
DYRK1A Q13627 3/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
PDE2A O00408 1/20 0.33
ULK1 O75385 1/20 0.32
CYP2C19 P33261 2/20 0.31
CYP2D6 P10635 1/20 0.31
RECQL P46063 1/20 0.31
PDE4A P27815 1/20 0.31
PTPN1 P18031 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280256 0.84 DYRK1A (0.43) IRAK4YTHDC1HSP90AB1LRRK2DYRK1A
SCHEMBL22280237 0.80 IRAK4 (0.36) IRAK4HSP90AB1DYRK1APDE2A
SCHEMBL22280370 0.80 IRAK4 (0.54) IRAK4CHUKCYP1A2DYRK1AULK1
SCHEMBL20555173 0.78 LRRK2 (0.50) XDHYTHDC1HSP90AB1CHUKLRRK2
SCHEMBL24059429 0.77 IRAK4 (0.49) IRAK4CHUKKDM4EULK1PDE4A
SCHEMBL20344046 0.76 XDH (0.42) XDHYTHDC1CHUKLRRK2PDE2A
SCHEMBL22182524 0.74 DYRK1A (0.41) IRAK4HSP90AB1LRRK2CYP1A2DYRK1A
SCHEMBL18394595 0.74 DYRK1A (0.38) IRAK4HSP90AB1DYRK1AKDM4E
SCHEMBL24136246 0.72 CHUK (0.68) XDHHSP90AB1CHUKLRRK2
SCHEMBL20588419 0.69 HSP90AB1 (0.39) IRAK4HSP90AB1LRRK2DYRK1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11208412-B2 Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) 2021-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11208412-B2 Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease LRRK2, WEE1, WEE2 XDH 3470/4885IRAK4 1018/4885YTHDC1 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.